Anti-vascular endothelial growth factor in age-related macular degeneration: Puzzle or a silent beginning!

被引：2
|
作者：
Natarajan, Sundaram [1 ]
机构：
[1] Aditya Jyot Eye Hosp Pvt Ltd, Bombay, Maharashtra, India
来源：
INDIAN JOURNAL OF OPHTHALMOLOGY | 2013年 / 61卷 / 09期
关键词：
INTRAVITREAL BEVACIZUMAB AVASTIN; VASCULAR-PERMEABILITY FACTOR; PHOTODYNAMIC THERAPY; INTRAOCULAR INFLAMMATION; RANIBIZUMAB LUCENTIS; PEGAPTANIB SODIUM; VEGF-TRAP; SAFETY; EFFICACY; NEOVASCULARIZATION;
D O I：
10.4103/0301-4738.119421
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：475 / 478
页数：4
相关论文
共 50 条
  • [21] Age-related Macular Degeneration and Cardiovascular Disease in the Era of Anti-Vascular Endothelial Growth Factor Therapies
    Wong, Tien Y.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (03) : 327 - 329
  • [22] Predictors of Response to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration
    Shah, Anjali R.
    Williams, Steven
    Baumal, Caroline R.
    Rosner, Bernard
    Duker, Jay S.
    Seddon, Johanna M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 163 : 154 - 166
  • [23] Systemic safety of intravitreal anti-vascular endothelial growth factor agents in age-related macular degeneration
    Dedania, Vaidehi S.
    Bakri, Sophie J.
    CURRENT OPINION IN OPHTHALMOLOGY, 2016, 27 (03) : 224 - 243
  • [24] Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
    Maruyama-Inoue, Maiko
    Kitajima, Yoko
    Yanagi, Yasuo
    Inoue, Tatsuya
    Kadonosono, Kazuaki
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [25] Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
    Maiko Maruyama-Inoue
    Yoko Kitajima
    Yasuo Yanagi
    Tatsuya Inoue
    Kazuaki Kadonosono
    Scientific Reports, 13
  • [26] When Should Anti-Vascular Endothelial Growth Factor Treatment Be Stopped in Age-Related Macular Degeneration?
    Gaudric, Alain
    Cohen, Salomon Y.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (01) : 4 - 6
  • [27] Anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration - Promises and pitfalls
    Csaky, K
    OPHTHALMOLOGY, 2003, 110 (05) : 879 - 881
  • [28] Examining the causes of dropout of anti-vascular endothelial growth factor therapy for age-related macular degeneration
    Sakuma, Ayano
    Wakuta, Makiko
    Noumi, Nanami
    Aoki, Ren
    Yoshikawa, Rina
    Higashijima, Fumiaki
    Ogata, Tadahiko
    Ota, Manami
    Kimura, Kazuhiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [29] Economic Evaluation of Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
    Brown, Melissa M.
    Brown, Gary C.
    JAMA OPHTHALMOLOGY, 2020, 138 (01) : 48 - 49
  • [30] Macular capillary plexuses during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration
    Hikichi, Taiichi
    Agarie, Mitsuko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
12345